Oscar Blanco

Salamanca, CL, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Deletion 9p drives B-ALL through the heterozygous inactivation of Pax5 and Cd72 in pre-leukemic cells.

Deletion 9p drives B-ALL through the heterozygous inactivation of Pax5 and Cd72 in pre-leukemic cells.

Journal: JCI insight
Published: February 17, 2026

Phenotypic Characterisation of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-cell Lymphocytosis.

Phenotypic Characterisation of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-cell Lymphocytosis.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 29, 2026

Phenotypic Characterization of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-Cell Lymphocytosis.

Phenotypic Characterization of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-Cell Lymphocytosis.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 29, 2026

Deletion of 9p drives B-ALL through heterozygous inactivation of Pax5 and Cd72 in preleukemic cells.

Deletion of 9p drives B-ALL through heterozygous inactivation of Pax5 and Cd72 in preleukemic cells.

Journal: JCI insight
Published: August 22, 2025

Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53).

Development and validation of a novel prognostic index for mantle cell lymphoma integrating TP53 mutations (MIPI53).

Journal: British journal of haematology
Published: July 24, 2025

miR-128-3p and miR-223-3p as Potential Biomarkers of Metabolic Dysfunction in Liver Tissue from Patients Undergoing Metabolic Bariatric Surgery.

miR-128-3p and miR-223-3p as Potential Biomarkers of Metabolic Dysfunction in Liver Tissue from Patients Undergoing Metabolic Bariatric Surgery.

Journal: Obesity surgery
Published: July 21, 2025

PD-1 Expression Promotes Immune Evasion in B-ALL.

PD-1 Expression Promotes Immune Evasion in B-ALL.

Journal: Hematology reports
Published: June 19, 2025

IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy.

IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy.

Journal: Blood
Published: July 03, 2024

Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease.

Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease.

Journal: British journal of haematology
Published: September 05, 2023

Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma.

Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma.

Journal: Journal for immunotherapy of cancer
Published: February 12, 2023

Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice.

Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice.

Journal: Nature communications
Published: January 18, 2023

Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets.

Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets.

Journal: American journal of hematology
Published: November 16, 2022
Showing 1-12 of 44

Last Updated: 09/26/2026